@DanGilonCardio retweeted
Today, in Tromso Norway, the IRAD Investigators will celebrate the 28th year of our scientific registry. We are the voice of 15,000 patients and 60 aortic centers striving to discover better solutions to aortic dissection: prevention, diagnosis and treatment. Life is precious.
Sounds great . Looking forward Dan
The first @escardio Cardio-Oncology conference has been announced ❤
@ICOSociety @TeresaLpezFdez1 @AHP_PAKS @NIO_PIB @OnkoNewsPL @Puls_Medycyny @MonikMajewska @DrRaulCordoba @AnnaBorowiec5
@rutkowskip1972 @drtarsh @DrRohitMoudgil @SverdlovAaron @bogda_koczwara @CancerCareMASCC
@DanGilonCardio retweeted
The first @escardio Cardio-Oncology conference has been announced ❤
@ICOSociety @TeresaLpezFdez1 @AHP_PAKS @NIO_PIB @OnkoNewsPL @Puls_Medycyny @MonikMajewska @DrRaulCordoba @AnnaBorowiec5
@rutkowskip1972 @drtarsh @DrRohitMoudgil @SverdlovAaron @bogda_koczwara @CancerCareMASCC
@DanGilonCardio retweeted
Wow!!! 🤯 New #ImpactFactor release and another record for @JACCJournals JACC: CardioOncology! < 5 years old and already the #9 Cardiology journal in the 🌎 and #2 #JACC subjournal. Amazing leadership from #BonnieKy! 🙂 @ArmenianSaro @ninianlang @dineshpmcc1 @PennThalheimer
@DanGilonCardio retweeted
Congrats to all nominees and @mikepicardmd ! I miss the @mghecho fam!
Congrats to our sonographers
⭐️Tim
⭐️Brittney
⭐️@LanqiHua
⭐️Alex
All nominated by @MGHCVFellows for contribution to teaching.
Impressive role of #echofirst experts (4 of 10 nominees).
❤️Congrats to overall winner Alex!
➡️@mikepicardmd won the senior faculty teaching award!
Congratulations
Thank you @uoftmedicine !
Looking forward to putting this support to minimize cardiovascular disease in people with cancer and maximize patients' chances of getting the best treatments possible while avoiding the risk of 🫀problems
#cardiooncology
@WCHospital @PMunkCardiacCtr
@DanGilonCardio retweeted
Congrats to @DSadlerMD for leading efforts to establish an international #cardioonc registry @ICOSociety #ACC24 #jacccardioonc
@DanGilonCardio retweeted
Another masterpiece by @DrJESalem & team. Full spectrum of irAE w/ ICI treatment!
New insights w/ myocarditis, myositis, MG (overlap syndrome). Shortest duration from initial exposure (31-33 days) & highest mortality (27.6%)
@TheLancet @eClinicalMed
thelancet.com/journals/eclin…
@DanGilonCardio retweeted
Generally, less cardiovascular events reported in patients with B-cell malignancies treated with zanubrutinib vs. ibrutinib (except for hypertension) @CardioOncology ashpublications.org/bloodadv…
@DanGilonCardio retweeted
Off press👇Last decade evolution of immune checkpoint inhibitors toxicities reported worldwide with evolution of risk factors, and outcomes. Myotoxicities (myocarditis, myositis mimicking myasthenia gravis) are strinkingly overlapping.
@CardioOncology sciencedirect.com/science/ar…
@DanGilonCardio retweeted
Extremely happy to share our latest work from the
@Transactivator lab! We show that the immunosuppressive PD-1/PD-L1 pathway is active in neonatal mouse hearts and required for regeneration 🫀Huge thanks to co-author @MiaoCui_713 and all other authors! nature.com/articles/s44161-0…
@DanGilonCardio retweeted
Replying to @dineshpmcc1
@dineshpmcc1 @juancplana @Dr_Mike_Fradley @SverdlovAaron @DoanNgo4 @drtarsh @md_arianemacedo @daniele_andres @AnaBaracCardio @SusannahStanwa1 @TomasNeilan @DSadlerMD @DrRohitMoudgil @Dr_Iakobishvili @kaufman_renato @CyclingDoctor @OncoCard_Ganken
Proud to see our study published by Cardio-Oncology @ICOSociety
@sdent_duke @TeresaLpezFdez1 @k_matusewicz @MonikMajewska @OnkoNewsPL @DrRaulCordoba
link.springer.com/article/10…
@DanGilonCardio retweeted
Thank you @ICOSociety and all our friends & collaborators around the 🌎: @sdent_duke @DSadlerMD Dr Alex Lyon & others supporting #cardioonc in Australia and 🌐
@HMRIAustralia @OzCvA @heartfoundation @UON_research @HNEHealth @RegionalHealth1 @cancerNSW @BCOSCardioOnc @thecsanz
🌏 IC-OS Around The World
Congrats to @DoanNgo4 and @SverdlovAaron, leaders in our Australia Chapter, along with their team who were recognized in the Newcastle Herald for their work on advancing #cardiooncology care and research at @HMRIAustralia.
Read the full article: newcastleherald.com.au/story…
#cardioonc #cardiooncology #cardioonclogyresearch #cardiooncaustralia #cardiooncologyaustralia #cardiologyaustralia #cardiology #oncology #treatcancerprotecthearts
@DanGilonCardio retweeted
🌏 IC-OS Around The World
Congrats to @DoanNgo4 and @SverdlovAaron, leaders in our Australia Chapter, along with their team who were recognized in the Newcastle Herald for their work on advancing #cardiooncology care and research at @HMRIAustralia.
Read the full article: newcastleherald.com.au/story…
#cardioonc #cardiooncology #cardioonclogyresearch #cardiooncaustralia #cardiooncologyaustralia #cardiologyaustralia #cardiology #oncology #treatcancerprotecthearts
@DanGilonCardio retweeted
"🎙️ Exciting new episode alert! 🚨👂 Join us as Dr. @KathrynRuddyMD , Professor of Oncology at @MayoClinic , explores the cardiovascular-toxicities of novel cancer therapies. Listen now: tinyurl.com/3w4jy783 🎧 #CardioOnc #Cardiotwitter #Cardiology
@DanGilonCardio retweeted
Replying to @PVenkateshMD
Thanks, Prashanth! That’s a great question. We are currently using the troponin in the context of the full clinical picture and symptoms to make treatment and management decisions, so we don’t have an absolute cutoff for holding Rx.
@DanGilonCardio retweeted
Excited to share this preprint. Serial, routine troponin-I screening in 428 consecutive patients treated with immunotherapy at our center was correlated with lower rates of grade 4-5 cardiovascular adverse events without a change in oncologic time on tx
medrxiv.org/content/10.1101/…
@DanGilonCardio retweeted
#MONITOR-HF in #HeartFailure2023
Remote monitoring ⬇️ #HeartFailure hospitalisations and ⬆️ quality of life.
@MDCaspi @Dr_Iakobishvili @PeterMoliner @RenatoVargas0 @SverdlovAaron @andre_casarsa @franknunes @wcostacardio


































